Skip to content

Author

Alberto Argentiero

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Human metapneumovirus prevention in children: emerging roles of monoclonal antibodies and vaccines

Human metapneumovirus (hMPV) is a major cause of acute lower respiratory tract infection in children, older adults, and individuals with underlying medical conditions. In pediatric populations, hMPV contributes substantially to hospitalizations, morbidity, and healthcare costs, yet no licensed vaccine or monoclonal ant...

Susanna Esposito, Valentina Fainardi, Gaia Giorgia Arnesano et al. · 0 citations
Review Open access Oct 2026

Artificial Intelligence in the Fight Against Antimicrobial Resistance: Applications in Diagnosis, Susceptibility Prediction, Precision Dosing, and Antibiotic Discovery

Background: Antimicrobial resistance (AMR) is a major global health threat, while conventional diagnostic, stewardship, dosing, and drug-development strategies remain limited by diagnostic delays, population-level decision-making, and a shrinking antibiotic pipeline. Artificial intelligence (AI) may help address these...

Susanna Esposito, Valentina Fainardi, Gaia Giorgia Arnesano et al. · 0 citations
Open access Sep 2026

A Pilot Study of VGGish-CNN as a Model for the Classification of Parkinson’s Disease from a Control Group Using Speech Impairment, Integrated with Explainable Artificial Intelligence

Introduction: Voice-based digital biomarkers have emerged as a promising, non-invasive approach for the early detection and monitoring of neurodegenerative disorders, particularly Parkinson’s disease (PD). Although voice recordings can be acquired easily using mobile health technologies, their integration into routine...

Mehdi Rashidi, Syed Taimoor Hussain Shah, Marco Greco et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.